Kang WZ, Zhong YX, Ma FH, Liu H, Ma S, Li Y, Hu HT, Li WK, Tian YT. Treatment strategies for gastric cancer during the COVID-19 pandemic. World J Clin Cases 2020; 8(21): 5099-5103 [PMID: 33269246 DOI: 10.12998/wjcc.v8.i21.5099]
Corresponding Author of This Article
Yan-Tao Tian, MD, PhD, Professor, Surgeon, Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing 100021, China. tianyantao@cicams.ac.cn
Research Domain of This Article
Oncology
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Wen-Zhe Kang, Yu-Xin Zhong, Fu-Hai Ma, Hao Liu, Shuai Ma, Yang Li, Hai-Tao Hu, Wei-Kun Li, Yan-Tao Tian, Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
Author contributions: Tian YT and Zhong YX designed the research; Kang WZ, Ma FH, Liu H, and Ma S analyzed the data and wrote the paper; Li Y, Hu HT, and Li WK collected the patient’s clinical data.
Supported byNational Natural Science Foundation of China, No. 81772642.
Conflict-of-interest statement: The authors declare that they have no conflicts of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Yan-Tao Tian, MD, PhD, Professor, Surgeon, Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing 100021, China. tianyantao@cicams.ac.cn
Received: June 10, 2020 Peer-review started: June 10, 2020 First decision: August 21, 2020 Revised: August 29, 2020 Accepted: September 22, 2020 Article in press: September 22, 2020 Published online: November 6, 2020
Abstract
The coronavirus disease 2019 pandemic has become a major global public health problem. Governments are taking the necessary steps to reduce the movement of people to contain the spread of the virus. However, these measures have caused considerable distress to patients with gastric cancer who are newly diagnosed or are undergoing treatment. In addition to the cancer, they must deal with longer waiting times for surgery and poor communication with doctors. Furthermore, gastric cancer patients generally have low immunity and a poor nutritional status, so they are a high-risk group for infection with the novel coronavirus. Therefore, it is necessary to formulate reasonable outpatient management strategies to reduce the adverse effects of the pandemic on their treatment. We summarize the management strategies for patients with gastric cancer during the pandemic.
Core Tip: The coronavirus disease 2019 outbreak has affected the treatment of many patients with gastric cancer. We need to adjust traditional treatment strategies to minimize the impact on patients. The progression of early gastric cancer is relatively slow, so the waiting time for surgery can be appropriately extended. We also need to develop strategies for management outside the hospital. It is particularly important to make full use of the network platform to establish good doctor-patient communication. In addition to the treatment of tumors, doctors should pay attention to the nutritional status and mental health of patients.
